Report Highlights
-
The U.S. medical plastics market is expected to reach almost 3.5 billion pounds by the end of 2010 and will grow at a compound annual growth rate (CAGR) of about 5%, consuming about 4.4 billion pounds by 2015.
-
Commodity thermoplastics dominate the market with a little more than 55% of total volume. This sector is estimated at nearly 2 billion pounds in 2010 and should increase at a compound annual growth rate (CAGR) of 4.8% to reach 2.5 billion pounds in 2015.
-
TPEs, engineering resins, and thermosets will show the most significant growth rates over the next 5 years although they only constitute about 20% of total volume. Of these, TPEs will experience the highest compound annual growth rate (CAGR) of 6.2%, from 68 million pounds in 2010 to 92 million pounds in 2015.
INTRODUCTION
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
Report Highlights
-
The U.S. medical plastics market will reach almost 2.7 billion pounds by the end of 2006 and will grow at an average annual growth rate (AAGR) of 4.4%, consuming over 3.3 billion pounds by 2011.
-
Commodity thermoplastics dominate the market with a little over 50% of total volume. This sector of the market should consume 1.7 billion pounds by the end of 2011, an AAGR of 4.2%.
-
TPEs represent the highest growth rate through the forecast period. In 2006, 137 million pounds were consumed. By the end of 2011, consumption will reach 181 million pounds, a 5.7% AAGR.
Report Highlights
-
The medical plastics market will rise at an average annual growth rate (AAGR) of 4.3% through 2008, from 2.2 billion pounds in 2002 to almost 2.9 billion pounds.
-
Disposable medical devices comprise about 60% of the total application volume.
-
Commodity thermoplastics represent just 50% of total product volume.
-
A slight shift to engineering resins, styrenics, thermosets and TPEs is forecast at the expense of commodity thermoplastics.
Report Highlights
-
The medical plastics market will reach almost 1.98 billion pounds by the end of 1999 and will grow at an annual rate of about 6%, consuming more than 2.6 billion pounds by 2004. Nondisposables comprise slightly more than 50% of total volume.
-
Commodity thermoplastics dominate the market with a little under 50% of total volume.
-
The Engineering resins market will grow at an annual rate of about 6.5%, consuming more than 0.3 billion pounds by 2004.
Related Reports
Recent Reports
Liquid Crystal Polymers: Global Markets
The global market for liquid crystal polymers is expected to grow from $957.5 million in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.1% from 2023 through 2028.
Plastics for Healthcare Packaging
The global market value of plastics for healthcare packaging is expected to grow from $32.1 billion in 2023 and should reach $46.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2023 to 2028.
Medical Plastics: Global Markets
The global market for medical plastics is estimated to increase from $25.6 billion in 2023 to reach $41.2 billion by 2028, at a compound annual growth rate (CAGR) of 10.0% from 2023 through 2028.
EMI/RFI: Materials and Technologies
The global market for EMI/RFI materials and technologies is expected to increase from $7.4 billion in 2023 to $9.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2023-2028.
Fluoropolymer Materials: Technologies and Global Markets
The global market volume for fluoropolymer materials is estimated to increase from 346.97 kilotons in 2023 to reach 442.79 kilotons by 2028, at a compound annual growth rate (CAGR) of 5.0% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More